This site is intended for Healthcare professionals only.

Lupin gets USFDA approval for generic psoriasis drug


Lupin gets USFDA approval for generic psoriasis drug

New Delhi: Drug major Lupin said it has received USFDA’s approval to market Clobetasol Propionate spray, used for treating plaque psoriasis, in the American market.

Lupin’s product is a generic version of Galderma Laboratories LP’s Clobex, which is indicated for the treatment of moderate to severe plaque psoriasis.

As per sales data, the spray had annual sales of around USD 30.5 million in the US.



Source: PTI
0 comment(s) on Lupin gets USFDA approval for generic psoriasis drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted